BioMarin Pharmaceutical (BMRN): Q2 EPS of -$0.27 may not be comparable to consensus of -$0.19....

|About: BioMarin Pharmaceutical ... (BMRN)|By:, SA News Editor
BioMarin Pharmaceutical (BMRN): Q2 EPS of -$0.27 may not be comparable to consensus of -$0.19. Revenue of $124M (+12.1% Y/Y) beats by $2.5M. Shares +1.1% AH. (PR)